[Featured Stock] HEM Pharma Plummets on First Day of KOSDAQ Listing

HMP Pharma is experiencing a decline on its first day listed on the KOSDAQ on the 5th.

As of 1:40 PM on the same day, HMP Pharma is trading at 17,910 KRW on the KOSDAQ market, down 22.13% from the public offering price of 23,000 KRW.

HMP Pharma is a specialized company in the human microbiome, operating a platform business related to customized healthcare and live biotherapeutic products (LBP) development based on its proprietary patented technology, the gut microbiome simulator (PMAS).

In the demand forecast for institutional investors, it recorded a competition rate of 1,220.7 to 1, confirming the public offering price at 23,000 KRW, exceeding the upper limit of the expected range (19,000 KRW). Subsequently, in the general subscription, it recorded a competition rate of 672.17 to 1.